Oriahnn and Vaginal bleeding between periods - a phase IV clinical study of FDA data

Summary:

Vaginal bleeding between periods is reported as a side effect among people who take Oriahnn (elagolix sodium,estradiol,norethindrone acetate; elagolix sodium), especially for people who are 40-49 old, have been taking the drug for < 1 month also take Folic Acid, and have Uterine leiomyoma.

The phase IV clinical study analyzes which people have Vaginal bleeding between periods when taking Oriahnn. It is created by eHealthMe based on reports of 604 people who have side effects when taking Oriahnn from the FDA, and is updated regularly.

What is Oriahnn?

Oriahnn has active ingredients of elagolix sodium,estradiol,norethindrone acetate; elagolix sodium. eHealthMe is studying from 604 Oriahnn users. Check the latest studies of Oriahnn.

What is Vaginal bleeding between periods?

Vaginal bleeding between periods is found to be associated with 576 drugs and 1,467 conditions by eHealthMe. Check the latest studies of Vaginal bleeding between periods.

On Jul, 12, 2026

604 people reported to have side effects when taking Oriahnn.
Among them, 30 people (4.97%) have Vaginal bleeding between periods.

Could Oriahnn cause Vaginal bleeding between periods?

Among these 30 people:

How long have people been on Oriahnn when they have Vaginal bleeding between periods? *

What is the age of people who have Vaginal bleeding between periods when taking Oriahnn? *

What are other drugs people take besides Oriahnn? *

What are other side effects people have besides Vaginal bleeding between periods? *

Hair Loss: 6 people, 20.00%
Amenorrhea (absence of a menstrual period in a woman of reproductive age): 5 people, 16.67%
Menstruation Irregular: 5 people, 16.67%
Nausea (feeling of having an urge to vomit): 4 people, 13.33%
Headache (pain in head): 4 people, 13.33%
Vaginal Bleeding: 3 people, 10.00%
Itching: 3 people, 10.00%
Dizziness: 2 people, 6.67%
Abdominal Distension: 2 people, 6.67%
Hot Flush (sudden feelings of heat): 2 people, 6.67%

What are the existing conditions these people have? *

Uterine Leiomyoma (uterine benign tumour derived from smooth muscle): 22 people, 73.33%
Vaginal Bleeding: 1 person, 3.33%
Heavy Or Prolong Menstrual Bleeding: 1 person, 3.33%
Haemorrhage (bleeding): 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Oriahnn and have Vaginal bleeding between periods?

- Check whether Vaginal bleeding between periods is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oriahnn:

Oriahnn (604 reports)

Vaginal bleeding between periods treatments and more:

Vaginal bleeding between periods (26,954 reports)

How severe was Vaginal bleeding between periods and when was it recovered:

Vaginal bleeding between periods in Oriahnn

Expand to all the drugs that have ingredients of elagolix sodium,estradiol,norethindrone acetate; elagolix sodium:

Vaginal bleeding between periods and drugs with ingredients of elagolix sodium,estradiol,norethindrone acetate; elagolix sodium

Sub-studies by age:

0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Oriahnn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vaginal bleeding between periods:

Vaginal bleeding between periods (576 drugs)

Browse all the conditions that are associated with Vaginal bleeding between periods:

Vaginal bleeding between periods (1,467 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on elagolix sodium,estradiol,norethindrone acetate; elagolix sodium (the active ingredients of Oriahnn) and Oriahnn (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.